mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
7e-05 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0008 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.002 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |